Türkçe 
English 
The use of artificial intelligence and machine learning in GxP environments must be managed carefully by pharmaceutical, biotechnology, medical-device, and other regulated manufacturers. AI/ML can support production-data analysis, early detection of deviation trends, interpretation of quality trends, maintenance forecasting, and insight generation from electronic batch records. As with any GxP digital technology, its use must be controlled with respect to data integrity, validation, traceability, and audit readiness.
Electronic Batch Record (EBR) systems can constitute a powerful data source for artificial intelligence applications because they collect structured data generated during production. However, if this data is to be used in quality decisions, it is essential to clearly define how AI outputs are generated, which datasets they are based on, within what limits they will be used, and where human approval will come into play. Centra's Electronic Batch Record (EBR) solution contributes to creating a more reliable data infrastructure for AI-powered quality analyses by digitizing production records.
The Basic Principles of Using AI/ML in a GxP Environment
What does AI/ML mean in a GxP environment?
AI stands for artificial intelligence, and ML stands for machine learning. In the GxP context, AI/ML refers to systems that generate data-driven predictions, classifications, recommendations, or analyses in quality, production, laboratory, validation, or documentation processes. These systems should be considered not only as technical tools but also as digital components that can have an impact on the quality system.
Why should the GxP effect be evaluated separately?
Because if an AI output influences a quality decision, that output must be verifiable and defensible. For example, if an AI model says "this batch carries a high risk of deviation," it must be defined what data this recommendation is based on and how it will be used.
How can AI/ML be used in EBR systems?
In EBR systems, AI/ML can be used to analyze batch records, find recurring deviation patterns, identify trends in process parameters, predict OOT risks, establish QA review priorities, and support data interpretation in ePQR reports. This usage can reduce the burden of manual data scanning for quality teams.
Should AI replace QA decision-making?
No. In a GxP environment, AI outputs should generally be considered as decision support tools. The final quality decision must be made by an authorized human user. AI can offer suggestions, flag risky records, or indicate trends; however, decisions such as release, deviation closure, or CAPA activation must be approved by authorized quality personnel.
Why is data integrity critical in AI/ML applications?
The results produced by AI systems depend on the quality of the data they are fed. A model working with incomplete, erroneous, contextually misleading, or untraceable data cannot produce reliable output. Therefore, EBR data must be generated in accordance with ALCOA++ principles and protected with timestamps, electronic signatures, audit trails, and source information.
What happens when AI works with incorrect data?
Incorrect data can create false risk signals or a false sense of security. For example, a model trained with missing deviation records might underestimate the true deviation risk. Therefore, data quality and context must be evaluated before using AI.
How should AI/ML validation be handled?
AI/ML validation in a GxP environment should be planned on a risk-based approach, according to the system's intended use. The data the model works with, the outputs it produces, whether these outputs affect quality decisions, and how users interpret these outputs should be documented. Test scenarios, performance criteria, and a model monitoring plan should be developed for critical use cases.
Is an AI model sufficient once it's been tested?
No. AI/ML systems can be affected by data changes over time. Therefore, model performance should be monitored, model updates should be managed with change control, and reassessments should be made in case of critical changes.
How can traceability be ensured in AI outputs?
In AI-powered systems, simply displaying the result is not enough. The data source used, analysis time, model version, rationale for the output, user evaluation, and the action taken must be traceable. Especially in GxP-related recommendations, it is important to link the model output to the audit trail or quality record.
Why is explainability important?
The auditor or quality team may want to understand why the AI output was produced. A model that is not fully explained and affects the quality decision can pose a risk from an audit perspective. Therefore, the level of explainability should be determined according to the intended use.
Frequently Asked Questions about AI/ML and GxP
How can AI-powered EBR be defended in an audit?
When defending an AI-powered EBR structure during an audit, the system's intended use, data sources, model version, validation approach, user role, human approval, and change control process must be clearly demonstrated. The auditor must be clearly informed whether AI is the ultimate decision-maker or a decision support tool.
What is the most important evidence to present to the auditor?
The most important evidence is demonstrating that the AI output is not being used uncontrollably. It must be possible to trace what data the model is working with, how the output is interpreted, and how the authorized person makes the decision.
How can AI be used in deviation management?
AI can be used in deviation management to classify recurring events, identify root cause patterns, suggest similar past deviations, and conduct trend analysis for CAPA effectiveness. However, deviation classification and CAPA decisions should be reviewed by the quality team.
Should AI automatically turn on CAPA?
In critical GxP processes, it is safer for AI to offer suggestions rather than directly and automatically triggering CAPA. The decision to trigger CAPA should be made after a risk assessment and with the approval of authorized QA personnel.
How can AI add value in ePQR processes?
In ePQR processes, AI can analyze large batch data points to more quickly identify trends, recurring deviations, parameter drifts, and process capability signals. This allows for a more data-driven and early warning-oriented approach to annual product quality assessments.
Should AI completely automate report writing?
AI can generate draft reports, extract summaries, and help interpret trends. However, for quality system outputs like ePQR, final evaluation, comment, and approval must be done by authorized quality personnel.
Is change control necessary for AI/ML?
Yes. If the AI model version, data source, algorithm logic, intended use, or decision impact changes, a change control process should be implemented. Especially for models with GxP (Gross Dominance) effects, an impact analysis should be conducted before any changes are made, and if necessary, a retesting and revalidation process should be applied.
Why is updating a model risky?
Model updates can produce different results for the same dataset. Since this can affect quality decisions, model changes should be managed in a controlled manner.
How does Centra EBR pave the way for AI/ML adoption?
Centra EBR can create a more reliable data infrastructure for AI/ML applications by digitally collecting production data, process parameters, electronic signatures, deviation records, audit trail information, and quality results. This makes AI-powered analyses more traceable, contextual, and relevant to the quality system.
How to get started with an AI/ML-supported EBR approach?
Businesses should first identify which AI use cases have a GxP impact, analyze data sources, define human validation points, and develop a validation strategy. To evaluate AI-powered EBR and quality analytics approaches, you can contact Centra through their information page.
